To Top

Archives for: March 17th, 2015

FDA Commissioner on Medical Product Innovation

Written by Lisa Sencen on March 17, 2015

FDA Advances Medical Product Innovation
By: Margaret A. Hamburg, M.D.

As posted on March 17, 2015 by FDA Voice

On March 10, I had the pleasure of appearing with my colleague Dr. Francis Collins before the Senate Committee on Health, Education, Labor and Pensions to testify at a hearing on the subject… Read More

Thoughtful Biosimilars Policy Is Best Way to Ensure Optimum Patient Outcomes

Written by on June 4, 2014

Biologic therapies have been lifesaving and life changing for the patients we represent – more than 30 million Americans with more than 7,000 rare diseases. Literally, hundreds of thousands of rare disease patients have found their lives bettered by biologics and we are collectively grateful to the innovators and companies… Read More